ReviewFrontiers in cell and developmental biology2026
Pregnancy-specific glycoproteins as molecular links between mesenchymal stromal cells and M2 macrophages in tissue repair: implications for cancer progression.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
After some decades of research on mesenchymal stromal cells (MSCs), they are not yet routinely used in clinical protocols. Even though various lines of investigation have pointed out that MSCs are therapeutic mainly owing to their secreted molecules, and a number of such molecules have been described, it is apparent that further understanding of MSC biology is still required to make them effective tools to treat diseases. This mini-review brings the perspective that MSCs do not act alone, but rather in concert with other cell types such as macrophages, to bring about tissue regeneration or, in some instances, unwanted consequences. In this context, the possible effects of pregnancy-specific glycoproteins produced by MSCs on macrophages, and consequences of this for tissue repair, cancer progression, and chimeric antigen receptor T cell therapy in solid tumors will be discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.